Agenebio

Therapeutic to treat amnestic mild cognitive impairment (aMCI) due to Alzheimer’s disease.

placeBaltimore, Maryland, United States calendar_todayFounded 2008 groups1 employees language agenebio.com

Registered entities

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%
Coming soon